Reflections on the Innovative Medicines Initiative

Nat Rev Drug Discov. 2011 May;10(5):321-2. doi: 10.1038/nrd3434.

Abstract

The pharmaceutical industry is developing new collaborative models for drug development. This article discusses the experience so far of the Innovative Medicines Initiative, which is currently the largest public-private partnership that is dedicated to pharmaceutical innovation, highlighting lessons learned for the success of precompetitive consortia.

MeSH terms

  • Cooperative Behavior
  • Drug Design*
  • Drug Industry / organization & administration*
  • Humans
  • Models, Organizational*
  • Public-Private Sector Partnerships / organization & administration
  • Research / organization & administration